Using Sources in the GDP

Size: px
Start display at page:

Download "Using Sources in the GDP"

Transcription

1 Using Sources in the GDP The following are five examples of sources that you may encounter while working on your GDP project. The information contained in each of these sources (shown by screen shot) was used to answer part of one of the GDP question sets by two students, Janling and Heidi. Janling and Heidi worked together on their GDP project using these sources to answer some of the GDP questions. For each, the question, source, and each of their answers are included here. Review each example with your lab partner and decide which of these examples demonstrate an appropriate use of the source, and if there are any other problems with the answer. Discuss the factors that you used to make your decision. Things to consider as you evaluate each example are: Is the source an appropriate one for the information presented? Did the student use his or her own words? Is the source cited appropriately? * Note: For this activity, you do not need to consider the completeness of the answer to each question; many questions in the GDP question set will require the use of multiple sources. These examples only include the information taken from the sources listed.

2 SOURCE #1 Question Set 1, Question 1: What are the most important symptoms that define the disorder? Source: s- Disease/Diagnosis/How- does- your- doctor- make- a- PD- diagnosis- Heidi s Answer: There are four main symptoms associated with Parkinson s Disease. The first is shaking or tremor. The second is bradykinesia, which is defined as slowness of movement. The third main symptom is, stiffness or rigidity of the arms, legs or trunk, and the fourth is postural instability, or trouble with balance and possible falls. Doctors generally do not consider a diagnosis of Parkinson s Disease unless the patient exhibits at least two of these symptoms over an extended period of time ( Disease/Diagnosis/How-does-your-doctor-make-a-PD-diagnosis-). Janling s Answer: A neurologist might make a diagnosis of Parkinson s Disease if a patient periodically exhibits at least two of the four main symptoms. These symptoms include bradykinesia (sluggish movement), shaking, stiffness, and balance difficulties (

3 SOURCE #2 Question Set 1, Question 8: What physical difficulties and challenges do patients face? Source: physical_symptoms.aspx Heidi s Answer: In addition to the diagnostic symptoms, patients with Parkinson s disease face many other physical challenges. For some patients, the neurological problems associated with the disease lead to difficulties controlling their bladder; others become constipated ( aspx). Many patients have difficulty controlling their lips, tongue, and swallowing, which can

4 cause difficulty talking and a buildup of saliva in the mouth. Others suffer from dry mouth because their saliva production is insufficient. ( about_parkinsons/signs_and_symptoms/physical_symptoms.aspx). Janling s Answer: In addition to the diagnostic symptoms, patients with Parkinson s disease face many other physical challenges. For some patients, the neurological problems associated with the disease lead to difficulties controlling their bladder; others become constipated ( aspx). Many patients have difficulty controlling their lips, tongue, and swallowing, which can cause difficulty talking and a buildup of saliva in the mouth. Others suffer from dry mouth because their saliva production is insufficient. ( about_parkinsons/signs_and_symptoms/physical_symptoms.aspx).

5 SOURCE #3 Question Set 2, Question 1: What is the normal role of the gene in the human cell? Be specific. Source: Heidi s answer: The Parkin protein is a component of the E3 ubiquitin ligase complex, which is required for the degradation of some proteins. It is encoded by the PARK2 gene in humans, and mutations that interfere with its function result in the death of dopaminergic cells (

6 SOURCE #4 Question Set 2, Question 1: What is the normal role of the gene in the human cell? Be specific. Source: D P Huynh, D R Scoles, T H Ho, M R Del Bigio and S M Pulst. Parkin is associated with actin filaments in neuronal and nonneural cells. Ann Neurol 48(5): (2000) Heidi s answer: The parkin protein is found in both neurons and non-neuronal cells. It can be detected in certain regions of the brain, including the basal ganglia and cerebral cortex, among others (Huynh et al., 2000). In these cells, the parkin protein is found associated with the actin cytoskeleton (Huynh et al., 2000). Janling s answer: The authors used Western blot analysis and immunohistochemistry to determine where the parkin protein is expressed. They detected protein in neuronal processes and the cytoplasm of neurons in the basal ganglia, midbrain, cerebellum, and cerebral cortex, colocalized with actin filaments but not microtubules (Huynh et al., 2000).

7 SOURCE #5 Question Set 2, Question 2: What types of mutations most commonly lead to the disorder and how do these mutations arise? Source: Heidi s Answer: There are several different mutations associated with Parkinson s Disease. In some patients, the causative mutation is a deletion of exon 4 in the PARK2 gene, while in at least one other, exons 3-7 were deleted. In addition, several different point mutations have been identified in a number of patients (OMIM). Janling s Answer: Parkinson s disease can be caused by either deletions or point mutations in the PARK2 gene. Kitada et al. (1998) identified two different deletions the first of exons 3-7, and the second of exon 4 in different patients. Other researchers have identified point mutations in patients with the disease (Hattori et al., 1998).

The PD You Don t See: Cognitive and Non-motor Symptoms

The PD You Don t See: Cognitive and Non-motor Symptoms The PD You Don t See: Cognitive and Non-motor Symptoms Benzi M. Kluger, M.D., M.S. Assistant Professor of Neurology and Psychiatry University of Colorado Denver Goals 1) What are the most common non-motor

More information

The PD You Don t See: Cognitive and Non-motor Symptoms

The PD You Don t See: Cognitive and Non-motor Symptoms The PD You Don t See: Cognitive and Non-motor Symptoms Benzi M. Kluger, M.D., M.S. Associate Professor of Neurology and Psychiatry Director Movement Disorders Center University of Colorado Denver Goals

More information

Kinematic Modeling in Parkinson s Disease

Kinematic Modeling in Parkinson s Disease Kinematic Modeling in Parkinson s Disease Alexander Hui Department of Bioengineering University of California, San Diego La Jolla, CA 92093 alexhui@ucsd.edu Abstract Parkinson s disease is a slowly progressing

More information

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier Test Disease Population Triad Disease name Parkinson disease 8, automsomal dominant OMIM number for disease 607060 Disease

More information

Prior Authorization with Quantity Limit Program Summary

Prior Authorization with Quantity Limit Program Summary Gocovri (amantadine) Prior Authorization with Quantity Limit Program Summary This prior authorization applies to Commercial, NetResults A series, SourceRx and Health Insurance Marketplace formularies.

More information

Evaluation of Parkinson s Patients and Primary Care Providers

Evaluation of Parkinson s Patients and Primary Care Providers Evaluation of Parkinson s Patients and Primary Care Providers 2018 Movement Disorders Half Day Symposium Elise Anderson MD Medical Co-Director, PBSI Movement Disorders 6/28/2018 1 Disclosures GE Speaker,

More information

Extrapyramidal Motor System. Basal Ganglia or Striatum. Basal Ganglia or Striatum 3/3/2010

Extrapyramidal Motor System. Basal Ganglia or Striatum. Basal Ganglia or Striatum 3/3/2010 Extrapyramidal Motor System Basal Ganglia or Striatum Descending extrapyramidal paths receive input from other parts of motor system: From the cerebellum From the basal ganglia or corpus striatum Caudate

More information

Neurodegenerative Disease. April 12, Cunningham. Department of Neurosciences

Neurodegenerative Disease. April 12, Cunningham. Department of Neurosciences Neurodegenerative Disease April 12, 2017 Cunningham Department of Neurosciences NEURODEGENERATIVE DISEASE Any of a group of hereditary and sporadic conditions characterized by progressive dysfunction,

More information

Visualization and simulated animations of pathology and symptoms of Parkinson s disease

Visualization and simulated animations of pathology and symptoms of Parkinson s disease Visualization and simulated animations of pathology and symptoms of Parkinson s disease Prof. Yifan HAN Email: bctycan@ust.hk 1. Introduction 2. Biochemistry of Parkinson s disease 3. Course Design 4.

More information

Genetic Parkinson s studying the few to treat the many

Genetic Parkinson s studying the few to treat the many Edinburgh Talk 01.12.12 Genetic Parkinson s studying the few to treat the many Miratul Muqit, Wellcome Trust Intermediate Fellow, Honorary Consultant Neurologist, MRC Protein Phosphorylation Unit, University

More information

Optimizing Clinical Communication in Parkinson s Disease:

Optimizing Clinical Communication in Parkinson s Disease: Optimizing Clinical Communication in Parkinson s Disease:,Strategies for improving communication between you and your neurologist PFNCA Symposium March 25, 2017 Pritha Ghosh, MD Assistant Professor of

More information

Differential Diagnosis of Hypokinetic Movement Disorders

Differential Diagnosis of Hypokinetic Movement Disorders Differential Diagnosis of Hypokinetic Movement Disorders Dr Donald Grosset Consultant Neurologist - Honorary Professor Institute of Neurological Sciences - Glasgow University Hypokinetic Parkinson's Disease

More information

Making Every Little Bit Count: Parkinson s Disease. SHP Neurobiology of Development and Disease

Making Every Little Bit Count: Parkinson s Disease. SHP Neurobiology of Development and Disease Making Every Little Bit Count: Parkinson s Disease SHP Neurobiology of Development and Disease Parkinson s Disease Initially described symptomatically by Dr. James Parkinson in 1817 in An Essay on the

More information

DOCTOR DISCUSSION GUIDE

DOCTOR DISCUSSION GUIDE DOCTOR DISCUSSION GUIDE FOR PEOPLE WITH PARKINSON S DISEASE (PD) GOCOVRI TM (amantadine) extended release capsules is the first and only FDA-approved prescription medication indicated to treat dyskinesia

More information

Parkinson s Foundation

Parkinson s Foundation Parkinson s Foundation PD ExpertBriefing: Diagnosis PD, Now What? Managing the First Few Years with Parkinson s Led By: Suketu Khandhar, M.D., Medical Director at Kaiser Permanente Northern California

More information

Non-Motor Symptoms of Parkinson s Disease

Non-Motor Symptoms of Parkinson s Disease Non-Motor Symptoms of Parkinson s Disease Samantha Holden, MD University of Colorado Movement Disorders MOTOR SYMPTOMS Rigidity Bradykinesia Tremor Gait Imbalance NON-MOTOR SYMPTOMS Dementia Urinary frequency

More information

For carers and relatives of people with frontotemporal dementia and semantic dementia. Newsletter

For carers and relatives of people with frontotemporal dementia and semantic dementia. Newsletter For carers and relatives of people with frontotemporal dementia and semantic dementia Newsletter AUGUST 2008 1 Welcome Welcome to the August edition of our CFU Support Group Newsletter. Thanks to all of

More information

Basal Ganglia. Steven McLoon Department of Neuroscience University of Minnesota

Basal Ganglia. Steven McLoon Department of Neuroscience University of Minnesota Basal Ganglia Steven McLoon Department of Neuroscience University of Minnesota 1 Course News Graduate School Discussion Wednesday, Nov 1, 11:00am MoosT 2-690 with Paul Mermelstein (invite your friends)

More information

Multiple System Atrophy

Multiple System Atrophy Multiple System Atrophy This document has been prepared to help you become more informed about Multiple System Atrophy. It is designed to answer questions about the condition and includes suggestions on

More information

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information

PARKINS ON CENTER. Parkinson s Disease: Diagnosis and Management. Learning Objectives: Recognition of PD OHSU. Disclosure Information OHSU PARKINS ON CENTER Parkinson s Disease: Diagnosis and Management for Every MD Disclosure Information Grants/Research Support: National Parkinson Foundation, NIH, Michael J. Fox Foundation Consultant:

More information

WELCOME. Parkinson s 101 for the Newly Diagnosed. Today s Topic: Parkinson s Basics presented by Cari Friedman, LCSW

WELCOME. Parkinson s 101 for the Newly Diagnosed. Today s Topic: Parkinson s Basics presented by Cari Friedman, LCSW WELCOME Parkinson s 101 for the Newly Diagnosed Today s Topic: Parkinson s Basics presented by Cari Friedman, LCSW Parkinson s Disease 101 Presenter for Today Cari Friedman, LCSW Patient and Family Service

More information

Moving fast or moving slow: an overview of Movement Disorders

Moving fast or moving slow: an overview of Movement Disorders Moving fast or moving slow: an overview of Movement Disorders Mini Medical School October 25, 2018 Heather Rigby, MD, FRCPC 2014 MFMER slide-1 2014 MFMER slide-2 Basal Ganglia Dysfunction - Movement Disorders

More information

What goes wrong with balance in Parkinson s Disease? Fay B Horak, PhD, PT Professor of Neurology Oregon Health and Science. CoM

What goes wrong with balance in Parkinson s Disease? Fay B Horak, PhD, PT Professor of Neurology Oregon Health and Science. CoM What goes wrong with balance in Parkinson s Disease? Fay B Horak, PhD, PT Professor of Neurology Oregon Health and Science CoM CoM Course Objectives Understand different types of balance systems affected

More information

MOVEMENT OUTLINE. The Control of Movement: Muscles! Motor Reflexes Brain Mechanisms of Movement Mirror Neurons Disorders of Movement

MOVEMENT OUTLINE. The Control of Movement: Muscles! Motor Reflexes Brain Mechanisms of Movement Mirror Neurons Disorders of Movement MOVEMENT 2 Dr. Steinmetz 3 OUTLINE The Control of Movement: Muscles! Motor Reflexes Brain Mechanisms of Movement Mirror Neurons Disorders of Movement Parkinson s Disease Huntington s Disease 1 4 TYPES

More information

Faculty. Joseph Friedman, MD

Faculty. Joseph Friedman, MD Faculty Claire Henchcliffe, MD, DPhil Associate Professor of Neurology Weill Cornell Medical College Associate Attending Neurologist New York-Presbyterian Hospital Director of the Parkinson s Institute

More information

Headway Victoria Epilepsy and Parkinson s Centre

Headway Victoria Epilepsy and Parkinson s Centre Headway Victoria Epilepsy and Parkinson s Centre Parkinson s Overview and Medication Shannon Oatway Community Education/ Awareness Coordinator What is Parkinson s Disease? The basics It is a chronic and

More information

III./3.1. Movement disorders with akinetic rigid symptoms

III./3.1. Movement disorders with akinetic rigid symptoms III./3.1. Movement disorders with akinetic rigid symptoms III./3.1.1. Parkinson s disease Parkinson s disease (PD) is the second most common neurodegenerative disorder worldwide after Alzheimer s disease.

More information

DYSKINESIA SYMPTOM TRACKER

DYSKINESIA SYMPTOM TRACKER DYSKINESIA SYMPTOM TRACKER FOR PEOPLE WITH PARKINSON S DISEASE (PD) GOCOVRI (amantadine) extended release capsules is the first and only FDA-approved prescription medication indicated to treat dyskinesia

More information

Cheyenne 11/28 Neurological Disorders II. Transmissible Spongiform Encephalopathy

Cheyenne 11/28 Neurological Disorders II. Transmissible Spongiform Encephalopathy Cheyenne 11/28 Neurological Disorders II Transmissible Spongiform Encephalopathy -E.g Bovine4 Spongiform Encephalopathy (BSE= mad cow disease), Creutzfeldt-Jakob disease, scrapie (animal only) -Sporadic:

More information

Parkinson s Disease Foundation. PD ExpertBriefing: Managing the Motor Symptoms in PD

Parkinson s Disease Foundation. PD ExpertBriefing: Managing the Motor Symptoms in PD Parkinson s Disease Foundation PD ExpertBriefing: Managing the Motor Symptoms in PD Led By: Sotirios A. Parashos, M.D. Minneapolis Clinic of Neurology and Struthers Parkinson's Center This session was

More information

The Limits of Harm Reduction? Neil McKeganey Centre for Substance Use Research West of Scotland Science Park Glasgow Scotland

The Limits of Harm Reduction? Neil McKeganey Centre for Substance Use Research West of Scotland Science Park Glasgow Scotland The Limits of Harm Reduction? Neil McKeganey Centre for Substance Use Research West of Scotland Science Park Glasgow Scotland Principle of Harm Reduction First Do No Harm Hippocratic Oath I will use treatment

More information

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York

Program Highlights. Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone Medical Center New York, New York Program Highlights David Swope, MD Associate Professor of Neurology Mount Sinai Health System New York, New York Michael Pourfar, MD Co-Director, Center for Neuromodulation New York University Langone

More information

ROLE AND IMPORTANCE OF REHABILITATION TREATMENT IN PATIENTS WITH PARKINSON S DISEASE VODA, Ioana¹; DOGARU, Gabriela¹, ²

ROLE AND IMPORTANCE OF REHABILITATION TREATMENT IN PATIENTS WITH PARKINSON S DISEASE VODA, Ioana¹; DOGARU, Gabriela¹, ² ROLE AND IMPORTANCE OF REHABILITATION TREATMENT IN PATIENTS WITH PARKINSON S DISEASE VODA, Ioana¹; DOGARU, Gabriela¹, ² ¹ University of Medicine and Pharmacy Cluj-Napoca ² Clinical Rehabilitation Hospital

More information

Movement Disorders: A Brief Overview

Movement Disorders: A Brief Overview Movement Disorders: A Brief Overview Albert Hung, MD, PhD Massachusetts General Hospital Harvard Medical School August 17, 2006 Cardinal Features of Parkinsonism Tremor Rigidity Bradykinesia Postural imbalance

More information

Understanding Parkinson s Disease Important information for you and your loved ones

Understanding Parkinson s Disease Important information for you and your loved ones Patient Education Understanding Parkinson s Disease Important information for you and your loved ones This handout explains the signs, symptoms, and possible treatments of Parkinson s disease. Parkinson

More information

M. Carranza M. R. Snyder J. Davenport Shaw T. A. Zesiewicz. Parkinson s Disease. A Guide to Medical Treatment

M. Carranza M. R. Snyder J. Davenport Shaw T. A. Zesiewicz. Parkinson s Disease. A Guide to Medical Treatment M. Carranza M. R. Snyder J. Davenport Shaw T. A. Zesiewicz Parkinson s Disease A Guide to Medical Treatment SEEd srl. All rights reserved Piazza Carlo Emanuele II, 19 10123 Torino, Italy Tel. 011.566.02.58

More information

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee

Parkinson Disease. Lorraine Kalia, MD, PhD, FRCPC. Presented by: Ontario s Geriatric Steering Committee Parkinson Disease Lorraine Kalia, MD, PhD, FRCPC Key Learnings Parkinson Disease (L. Kalia) Key Learnings Parkinson disease is the most common but not the only cause of parkinsonism Parkinson disease is

More information

Parkinson s Disease. Sirilak yimcharoen

Parkinson s Disease. Sirilak yimcharoen Parkinson s Disease Sirilak yimcharoen EPIDEMIOLOGY ~1% of people over 55 years Age range 35 85 years peak age of onset is in the early 60s ~5% of cases characterized by an earlier age of onset (typically

More information

Chapter 8. Parkinsonism. M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University.

Chapter 8. Parkinsonism. M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University. Chapter 8 Parkinsonism M.G.Rajanandh, Dept. of Pharmacy Practice, SRM College of Pharmacy, SRM University. Definition of Parkinson s Disease Parkinson's disease is a progressive, neurodegenerative disease

More information

The symptoms of the Parkinson s disease may vary from person to person. The symptoms might include the following:

The symptoms of the Parkinson s disease may vary from person to person. The symptoms might include the following: 1 PARKINSON S DISEASE Parkinson's disease is a long term disease related to the central nervous system that mainly affects the motor system, resulting in the loss of dopamine, which helps in producing

More information

Parkinson s disease Therapeutic strategies. Surat Tanprawate, MD Division of Neurology University of Chiang Mai

Parkinson s disease Therapeutic strategies. Surat Tanprawate, MD Division of Neurology University of Chiang Mai Parkinson s disease Therapeutic strategies Surat Tanprawate, MD Division of Neurology University of Chiang Mai 1 Scope Modality of treatment Pathophysiology of PD and dopamine metabolism Drugs Are there

More information

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)

Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) A Neurosurgical Treatment for Parkinson s Disease Parkinson s Disease Parkinson s disease is a common neurodegenerative disorder that affects about

More information

Date of Referral: Enhanced Primary Care Pathway: Parkinson s Disease

Date of Referral: Enhanced Primary Care Pathway: Parkinson s Disease Specialist LINK Linking Physicians CALGARY AND AREA Patient Name: Date of Birth: Calgary RHRN: PHN / ULI: Date of Referral: Referring MD: Fax: Today s Date: CONFIRMATION: TRIAGE CATEGORY: REFERRAL STATUS:

More information

Treatment of Parkinson s Disease: Present and Future

Treatment of Parkinson s Disease: Present and Future Treatment of Parkinson s Disease: Present and Future Karen Blindauer, MD Professor of Neurology Director of Movement Disorders Program Medical College of Wisconsin Neuropathology: Loss of Dopamine- Producing

More information

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria)

Pathogenesis of Degenerative Diseases and Dementias. D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Pathogenesis of Degenerative Diseases and Dementias D r. Ali Eltayb ( U. of Omdurman. I ). M. Path (U. of Alexandria) Dementias Defined: as the development of memory impairment and other cognitive deficits

More information

Surgical Management of Parkinson s Disease

Surgical Management of Parkinson s Disease Surgical Management of Parkinson s Disease Shyamal H. Mehta MD, PhD Assistant Professor of Neurology, Movement Disorders Division Mayo Clinic College of Medicine Mayo Clinic, Arizona 2016 MFMER slide-1

More information

Basal Ganglia General Info

Basal Ganglia General Info Basal Ganglia General Info Neural clusters in peripheral nervous system are ganglia. In the central nervous system, they are called nuclei. Should be called Basal Nuclei but usually called Basal Ganglia.

More information

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE

ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging. Dr. Olav E. Krigolson Lecture 5: PARKINSONS DISEASE ASHI691: Why We Fall Apart: The Neuroscience and Neurophysiology of Aging Dr. Olav E. Krigolson krigolson@uvic.ca Lecture 5: PARKINSONS DISEASE The Basal Ganglia Primary motor cortex Execution of movement

More information

Data Collection Worksheets

Data Collection Worksheets Data Collection Worksheets PhenX Measure: Antipsychotic Medication Extrapyramidal Side Effects (#661600) PhenX Protocol: Antipsychotic Medication Extrapyramidal Side Effects (#661601) Date of Interview/Examination/Bioassay

More information

Chapter 8. Control of movement

Chapter 8. Control of movement Chapter 8 Control of movement 1st Type: Skeletal Muscle Skeletal Muscle: Ones that moves us Muscles contract, limb flex Flexion: a movement of a limb that tends to bend its joints, contraction of a flexor

More information

Issues for Patient Discussion

Issues for Patient Discussion onmotor complications radykinesia Screening Tools asked PD micrographia eurodegeneration Designed for Use by Family Practitioners remor on-off opamine agonists tiffness depression ostural instability wearing

More information

Parkinson s Disease. Patients will ask you. 8/14/2015. Objectives

Parkinson s Disease. Patients will ask you. 8/14/2015. Objectives Parkinson s Disease Jean Van Kingsley MS, FNP-BC Objectives Describe the pathophysiolgy of PD. Review clinical charachteristics of PD. Identify management strategies, to maximize functional status. Recognize

More information

Precise evaluation of motor and non-motor dysfunction in Parkinson s disease using the KINARM

Precise evaluation of motor and non-motor dysfunction in Parkinson s disease using the KINARM Precise evaluation of motor and non-motor dysfunction in Parkinson s disease using the KINARM Project lead: Dr. Ron Levy Pauline Gaprielian, Dr. Stephen H. Scott, Dr. Giovanna Pari Queen s University,

More information

Enhanced Primary Care Pathway: Parkinson s Disease

Enhanced Primary Care Pathway: Parkinson s Disease Enhanced Primary Care Pathway: Parkinson s Disease 1. Focused summary of PD relevant to primary care Parkinson s Disease (PD) and Essential tremor (ET) are two of the most common movement disorders encountered

More information

Parkinsons Disease & Movement Disorder Aug 11-13, Frankfurt l Dr. Geeta Shroff

Parkinsons Disease & Movement Disorder Aug 11-13, Frankfurt l Dr. Geeta Shroff USE OF HUMAN EMBRYONIC STEM CELLS IN THE TREATMENT OF PARKINSON S DISEASE Dr. Geeta Shroff Founder and Medical Director, Nutech Mediworld CONDITIONS TREATED Spinal Cord Injury Cell Culture Technology Diabetes

More information

Biological Bases of Behavior. 8: Control of Movement

Biological Bases of Behavior. 8: Control of Movement Biological Bases of Behavior 8: Control of Movement m d Skeletal Muscle Movements of our body are accomplished by contraction of the skeletal muscles Flexion: contraction of a flexor muscle draws in a

More information

Form B3L: UPDRS Part III Motor Examination 1

Form B3L: UPDRS Part III Motor Examination 1 Initial Visit Packet NACC Uniform Data Set (UDS) LBD MODULE Form B3L: UPDRS Part III Motor Examination 1 ADC name: Subject ID: Form date: / / Visit #: Examiner s initials: INSTRUCTIONS: This form is to

More information

Basal ganglia Sujata Sofat, class of 2009

Basal ganglia Sujata Sofat, class of 2009 Basal ganglia Sujata Sofat, class of 2009 Basal ganglia Objectives Describe the function of the Basal Ganglia in movement Define the BG components and their locations Describe the motor loop of the BG

More information

Parkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD

Parkinson s Disease Initial Clinical and Diagnostic Evaluation. J. Timothy Greenamyre, MD, PhD Parkinson s Disease Initial Clinical and Diagnostic Evaluation J. Timothy Greenamyre, MD, PhD Involuntary tremulous motion, with lessened muscular power, in parts not in action and even when supported

More information

Inside Your Patient s Brain Michelle Peterson, APRN, CNP Centracare Stroke and Vascular Neurology

Inside Your Patient s Brain Michelle Peterson, APRN, CNP Centracare Stroke and Vascular Neurology Inside Your Patient s Brain Michelle Peterson, APRN, CNP Centracare Stroke and Vascular Neurology Activity Everyone stand up, raise your right hand, tell your neighbors your name 1 What part of the brain

More information

SIMPSON-ANGUS SCALE (SAS)

SIMPSON-ANGUS SCALE (SAS) SIMPSON-ANGUS SCALE (SAS) www.cnsforum.com 1 1. GAIT: The patient is examined as he walks into the examining room, his gait, the swing of his arms, his general posture, all form the basis for an overall

More information

PMT. Mark Scheme (Results) January GCE Biology (6BI05) Paper 01 Energy, Exercise and Coordination

PMT. Mark Scheme (Results) January GCE Biology (6BI05) Paper 01 Energy, Exercise and Coordination Scheme (Results) January 2012 GCE Biology (6BI05) Paper 01 Energy, Exercise and Coordination Edexcel and BTEC Qualifications Edexcel and BTEC qualifications come from Pearson, the world s leading learning

More information

Modeling Parkinson s disease: systems to test gene-environment interactions

Modeling Parkinson s disease: systems to test gene-environment interactions Modeling Parkinson s disease: systems to test gene-environment interactions Jason Cannon, Ph.D. Pittsburgh Institute of Neurodegenerative Diseases University of Pittsburgh Outline Parkinson s disease (PD)

More information

Understanding. Tremor. Christy, diagnosed with essential tremor in childhood, with her husband, Ben.

Understanding. Tremor. Christy, diagnosed with essential tremor in childhood, with her husband, Ben. Understanding Tremor Christy, diagnosed with essential tremor in childhood, with her husband, Ben. What Is Tremor? A tremor is the repetitive, involuntary, rhythmic trembling of one or more parts of the

More information

The Shaking Palsy of 1817

The Shaking Palsy of 1817 The Shaking Palsy of 1817 A Treatment Update on Parkinson s Disease Dr Eitzaz Sadiq Neurologist CH Baragwanath Acadamic Hospital Parkinson s Disease O Premature death of dopaminergic neurons O Symptoms

More information

BANISH BRAIN FOG: Chapter 5 workbook Copyright 2016 by datis kharrazian published by elephant press Page 1

BANISH BRAIN FOG: Chapter 5 workbook Copyright 2016 by datis kharrazian published by elephant press Page 1 The Brain Function Assessment Form (BFAF) will help you see which symptoms relate to specific areas of your brain. I suggest printing out a few copies so you can take the test several times as you go along

More information

Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B.

Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B. UvA-DARE (Digital Academic Repository) Clinimetrics, clinical profile and prognosis in early Parkinson s disease Post, B. Link to publication Citation for published version (APA): Post, B. (2009). Clinimetrics,

More information

Palladotomy and Pallidal Deep Brain Stimulation

Palladotomy and Pallidal Deep Brain Stimulation Palladotomy and Pallidal Deep Brain Stimulation Parkinson s disease Parkinson s Disease is a common neurodegenerative disorder that affects about 1:100 individuals over the age of 60. In a small percentage

More information

PARKINSON S DISEASE MEDICAL ASSESSMENT FORM FOR SOCIAL SECURITY DISABILITY APPLICATION

PARKINSON S DISEASE MEDICAL ASSESSMENT FORM FOR SOCIAL SECURITY DISABILITY APPLICATION PARKINSON S DISEASE MEDICAL ASSESSMENT FORM FOR SOCIAL SECURITY DISABILITY APPLICATION TO: RE: SSN: Dr: Please answer the following questions concerning your patient s Parkinson s disease and other impairments.

More information

Using Resting-State Functional Connectivity of the Basal Ganglia as a Biomarker for Symptoms of Parkinson's Disease

Using Resting-State Functional Connectivity of the Basal Ganglia as a Biomarker for Symptoms of Parkinson's Disease Illinois Math and Science Academy DigitalCommons@IMSA Student Publications & Research Student Works 4-2015 Using Resting-State Functional Connectivity of the Basal Ganglia as a Biomarker for Symptoms of

More information

DEEP BRAIN STIMULATION SURGICAL CANDIDACY EVALUATION FORM

DEEP BRAIN STIMULATION SURGICAL CANDIDACY EVALUATION FORM Name: MR#: Date: DEEP BRAIN STIMULATION SURGICAL CANDIDACY EVALUATION FORM Referring Physician s Name: Primary Care Provider s Name: 1. What was/were your first movement disorder symptoms? What did you

More information

Part I Parkinson Disease Diagnosis and Treatment

Part I Parkinson Disease Diagnosis and Treatment Part I Parkinson Disease Diagnosis and Treatment Parkinson Disease A Health Policy Perspective. Edited by Wayne Martin, Oksana Suchowersky, Katharina Kovacs Burns, and Egon Jonsson Copyright 2010 WILEY-VCH

More information

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia

What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia What if it s not Alzheimer s? Update on Lewy body dementia and frontotemporal dementia Dementia: broad term for any acquired brain condition impairing mental function such that ADLs are impaired. Includes:

More information

Pilates as a modality to increase movement and improve quality of life for those suffering from Parkinson s Disease

Pilates as a modality to increase movement and improve quality of life for those suffering from Parkinson s Disease Pilates as a modality to increase movement and improve quality of life for those suffering from Parkinson s Disease Miranda Handke 23 July 2016 Comprehensive Global Format Brisbane, Australia 2015 Abstract

More information

A. General features of the basal ganglia, one of our 3 major motor control centers:

A. General features of the basal ganglia, one of our 3 major motor control centers: Reading: Waxman pp. 141-146 are not very helpful! Computer Resources: HyperBrain, Chapter 12 Dental Neuroanatomy Suzanne S. Stensaas, Ph.D. March 1, 2012 THE BASAL GANGLIA Objectives: 1. What are the main

More information

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease

PARKINSON S DISEASE. Nigrostriatal Dopaminergic Neurons 5/11/16 CARDINAL FEATURES OF PARKINSON S DISEASE. Parkinson s disease 5/11/16 PARKINSON S DISEASE Parkinson s disease Prevalence increases with age (starts 40s60s) Seen in all ethnic groups, M:F about 1.5:1 Second most common neurodegenerative disease Genetics role greater

More information

Exercise as Medicine The Role of Rehabilitation Professionals in Helping to Treat Parkinson's Disease Rehabilitation Services

Exercise as Medicine The Role of Rehabilitation Professionals in Helping to Treat Parkinson's Disease Rehabilitation Services Exercise as Medicine The Role of Rehabilitation Professionals in Helping to Treat Parkinson's Disease Katie Parafinczuk PT, DPT, NCS Redwood City, CA Rehabilitation Services My Background Kathleen.n.parafinczuk@kp.org

More information

A. General features of the basal ganglia, one of our 3 major motor control centers:

A. General features of the basal ganglia, one of our 3 major motor control centers: Reading: Waxman pp. 141-146 are not very helpful! Computer Resources: HyperBrain, Chapter 12 Dental Neuroanatomy Suzanne S. Stensaas, Ph.D. April 22, 2010 THE BASAL GANGLIA Objectives: 1. What are the

More information

It is used to treat or prevent upset stomach and throwing up. What do I need to tell my doctor BEFORE I take this drug?

It is used to treat or prevent upset stomach and throwing up. What do I need to tell my doctor BEFORE I take this drug? PATIENT & CAREGIVER EDUCATION Ondansetron Brand Names: US Zofran; Zofran ODT [DSC]; Zuplenz Brand Names: Canada Ondissolve ODF; Zofran ODT What is this drug used for? It is used to treat or prevent upset

More information

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits

Overview. Overview. Parkinson s disease. Secondary Parkinsonism. Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits Overview Overview Parkinsonism: Motor symptoms associated with impairment in basal ganglia circuits The differential diagnosis of Parkinson s disease Primary vs. Secondary Parkinsonism Proteinopathies:

More information

PARKINSON S MEDICATION

PARKINSON S MEDICATION PARKINSON S MEDICATION History 1940 50 s Neurosurgeons operated on basal ganglia. Improved symptoms. 12% mortality 1960 s: Researchers identified low levels of dopamine caused Parkinson s leading to development

More information

USING PRECISION MEDICINE TO HELP PATIENTS WITH PARKINSON S DISEASE. The Michael J. Fox Foundation for Parkinson s Research

USING PRECISION MEDICINE TO HELP PATIENTS WITH PARKINSON S DISEASE. The Michael J. Fox Foundation for Parkinson s Research USING PRECISION MEDICINE TO HELP PATIENTS WITH PARKINSON S DISEASE The Michael J. Fox Foundation for Parkinson s Research MJFF IS THE WORLD S LARGEST NONPROFIT FUNDER OF PD RESEARCH Our Mission We are

More information

10th Medicine Review Course st July Prakash Kumar

10th Medicine Review Course st July Prakash Kumar 10th Medicine Review Course 2018 21 st July 2018 Drug Therapy for Parkinson's disease Prakash Kumar National Neuroscience Institute Singapore General Hospital Sengkang General Hospital Singhealth Duke-NUS

More information

METHOD FOR PREDICTING THE EARLY ONSET AND SEVERITY OF LEVODOPA INDUCED DYSKINESIA (LID) IN SUBJECTS DIAGNOSED OF PARKINSON S DISEASE

METHOD FOR PREDICTING THE EARLY ONSET AND SEVERITY OF LEVODOPA INDUCED DYSKINESIA (LID) IN SUBJECTS DIAGNOSED OF PARKINSON S DISEASE METHOD FOR PREDICTING THE EARLY ONSET AND SEVERITY OF LEVODOPA INDUCED DYSKINESIA (LID) IN SUBJECTS DIAGNOSED OF PARKINSON S DISEASE Madrid, 14 de noviembre de 2017 1. THE TEAM AND THE INSTITUTIONS BEHIND

More information

Parkinson's Disease KP Update

Parkinson's Disease KP Update Parkinson's Disease KP Update Andrew Imbus, PA-C Neurology, Movement Disorders Kaiser Permanente, Los Angeles Medical Center No disclosures "I often say now I don't have any choice whether or not I have

More information

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE

Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE Scott J Sherman MD, PhD The University of Arizona PARKINSON DISEASE LEARNING OBJECTIVES The Course Participant will: 1. Be familiar with the pathogenesis of Parkinson s Disease (PD) 2. Understand clinical

More information

Organization of the nervous system 2

Organization of the nervous system 2 Organization of the nervous system 2 Raghav Rajan Bio 334 Neurobiology I August 22nd 2013 1 Orienting within the brain absolute axes and relative axes SUPERIOR (above) ANTERIOR (in front) Anterior/Posterior,

More information

Parkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. What is Parkinson s Disease?

Parkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. What is Parkinson s Disease? Parkinson s Disease Webcast January 31, 2008 Jill Ostrem, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center, its medical staff or Patient

More information

RAMBAM. Revolutionary New Treatment for Parkinson s Disease Tremors. Health Care Campus. Information Guide & Treatment Options

RAMBAM. Revolutionary New Treatment for Parkinson s Disease Tremors. Health Care Campus. Information Guide & Treatment Options RAMBAM Health Care Campus Revolutionary New Treatment for Parkinson s Disease Tremors Information Guide & Treatment Options Table of Contents Introduction 1 Parkinson s Disease Symptoms: Tremors 2 Current

More information

Parkinson s Disease. Diagnostic Symptoms

Parkinson s Disease. Diagnostic Symptoms Parkinson s Disease What is Parkinson s disease? Parkinson s disease (PD) is a progressive disease that affects an individual s movement and motor skills. It is progressive in that symptoms of the disease

More information

Parkinson s Disease and Driving

Parkinson s Disease and Driving Parkinson s Disease and Driving Virginia Mason Mary Muszynski Occupational Therapist Arin Sumerwell Occupational Therapist 2 Driving and Parkinson s From Parkinson s Foundation website: The ability to

More information

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Assistant Professor of Neurology + Pharmacologic Treatment of Parkinson s Disease Nicholas J. Silvestri, M.D. Assistant Professor of Neurology + Overview n Brief review of Parkinson s disease (PD) n Clinical manifestations n Pathophysiology

More information

METHOD FOR PREDICTING THE EARLY ONSET AND SEVERITY OF LEVODOPA INDUCED DYSKINESIA (LID) IN SUBJECTS DIAGNOSED OF PARKINSON S DISEASE

METHOD FOR PREDICTING THE EARLY ONSET AND SEVERITY OF LEVODOPA INDUCED DYSKINESIA (LID) IN SUBJECTS DIAGNOSED OF PARKINSON S DISEASE METHOD FOR PREDICTING THE EARLY ONSET AND SEVERITY OF LEVODOPA INDUCED DYSKINESIA (LID) IN SUBJECTS DIAGNOSED OF PARKINSON S DISEASE Con el respaldo de ACCIÓ Madrid, 14 de noviembre de 2017 1. THE TEAM

More information

FOR PARKINSON S DISEASE XADAGO NEXT?

FOR PARKINSON S DISEASE XADAGO NEXT? FOR PARKINSON S DISEASE XADAGO can increase your daily on time without troublesome dyskinesia 1 Please see the complete Important Safety Information on pages 12-13 and the accompanying full Prescribing

More information

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types Background Movement Disorders Psychology 372 Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides Early Studies Found some patients with progressive weakness

More information

SPEAKING UP ABOUT OFF PERIODS

SPEAKING UP ABOUT OFF PERIODS SPEAKING UP ABOUT OFF PERIODS A doctor discussion guide for people living with Parkinson s Actor portrayal What exactly are OFF periods? OFF periods are when Parkinson s symptoms return between regular

More information

PD AND FALLS J U MALLYA FALLS AWARENESS MEETING

PD AND FALLS J U MALLYA FALLS AWARENESS MEETING PD AND FALLS J U MALLYA FALLS AWARENESS MEETING 23-09-2016 PD Chronic Progressive neurodegenerative disease Motor system disorder Degeneration of Dopaminergic neurons in Substantia nigra in the midbrain.

More information

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology

Pharmacologic Treatment of Parkinson s Disease. Nicholas J. Silvestri, M.D. Associate Professor of Neurology + Pharmacologic Treatment of Parkinson s Disease Nicholas J. Silvestri, M.D. Associate Professor of Neurology + Disclosures n NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT + Learning

More information

(safinamide) tablets

(safinamide) tablets FOR PARKINSON S DISEASE (PD) GET TO KNOW XADAGO can increase your daily on time without troublesome dyskinesia (uncontrolled movement) Please see the complete on pages 14-15 and For Parkinson s disease

More information